Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Afatinib often causes skin problems that need proactive management.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Immune checkpoint inhibitors can cause skin issues, which may indicate a good cancer response, and dermatologists are important in managing these effects.

JAK inhibitors may reduce depression in people with alopecia areata.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Activating certain cells in hair follicles can prevent hair loss caused by cancer treatments.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

HDAC1 is crucial for skin development and preventing tumors.

Upadacitinib improved multiple immune-related conditions in one patient.

Sorafenib often causes skin side effects, indicating effective cancer treatment.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

JAK inhibitors can cause severe acne, limiting their use for hair regrowth.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

JAK inhibitors may help treat alopecia areata by restoring hair growth.

JAK inhibitors may help treat alopecia areata by restoring hair growth.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Dimeric peptide derivatives could help hair growth and treat hair loss safely.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

High levels of ODC and a mutant Ha-ras gene cause tumors in mice.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.